Insights

According to China’s FDA (CFDA), the State Council issued two five-year plans on food and drug safety earlier this year that will impact analytical instrument manufacturers. According to the plan, 97% of agricultural products are required to meet quality standards by 2020. The plan on drug safety states that pharmaceutical drug quality is to be improved, calling for the approval of 289 generic drugs, as well as the reform of 3,050 national drug standards and 500 medical equipment standards by 2020. Read on to find out how these changes will impact instrument makers and more. Discuss

Spotlight on the Emerging Market in China

Upon studying the analytical and life science instrument market in China, along with life science lab budgets, The Science Advisory Board has found that Asian markets are growing faster than scientific markets in the US and Europe. China in particular is of great interest because of the size and growth of their nearly $6 billion market. Discuss

The Enduring Power of Branding in the Antibody Market

Here at The Science Advisory Board we recognize the growing market for research antibodies. One of the first questions we asked our members was “When thinking about commercially available antibodies, which brands come to mind?” We received hundreds of brands, but about 20 were the most frequent in our “mindshare” results. Discuss

Life Science Marketing: Change and Constancy

At The Science Advisory Board we surveyed over 1,000 of our members to better understand their thoughts and opinions about current life science marketing techniques. This study will discuss some of our findings related to influencer marketing, sponsored content and experiential marketing. Use this post as a resource to learn more about how marketing influences your lab purchases as well as insight on your peers attitudes towards such tactics. Discuss

« prev 1 2 3